HK1220118A1 - 甲磺酸伊馬替尼α結晶的製備及其藥物組合物 - Google Patents

甲磺酸伊馬替尼α結晶的製備及其藥物組合物

Info

Publication number
HK1220118A1
HK1220118A1 HK16108159.2A HK16108159A HK1220118A1 HK 1220118 A1 HK1220118 A1 HK 1220118A1 HK 16108159 A HK16108159 A HK 16108159A HK 1220118 A1 HK1220118 A1 HK 1220118A1
Authority
HK
Hong Kong
Prior art keywords
preparation
pharmaceutical composition
imatinib mesylate
alpha crystal
mesylate alpha
Prior art date
Application number
HK16108159.2A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1220118A1 publication Critical patent/HK1220118A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK16108159.2A 2012-08-04 2016-07-12 甲磺酸伊馬替尼α結晶的製備及其藥物組合物 HK1220118A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210281256.5A CN103570676B (zh) 2012-08-04 2012-08-04 甲磺酸伊马替尼α结晶的制备及其药物组合物

Publications (1)

Publication Number Publication Date
HK1220118A1 true HK1220118A1 (zh) 2017-04-28

Family

ID=50043461

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16108159.2A HK1220118A1 (zh) 2012-08-04 2016-07-12 甲磺酸伊馬替尼α結晶的製備及其藥物組合物

Country Status (2)

Country Link
CN (2) CN103570676B (zh)
HK (1) HK1220118A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20210305A1 (ar) * 2019-05-16 2023-01-30 Aerovate Therapeutics Inc صيغ إيماتينيب وتصنيعها واستخداماتها
CN111961031A (zh) * 2019-05-20 2020-11-20 浙江尖峰药业有限公司 一种甲磺酸伊马替尼的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1922314A1 (en) * 2005-08-26 2008-05-21 Novartis AG Delta and epsilon crystal forms of imatinib mesylate
EP2311821A1 (en) * 2006-04-27 2011-04-20 Sicor, Inc. Polymorphic form of Imatinib mesylate and processes for its preparation
CN102040587A (zh) * 2009-10-26 2011-05-04 韩南银 一种甲磺酸伊马替尼的制备方法
CN102190649B (zh) * 2011-03-28 2013-01-02 齐鲁天和惠世制药有限公司 一种制备α型甲磺酸伊马替尼的方法
CN102617552A (zh) * 2012-04-06 2012-08-01 江南大学 一种制备α晶型甲磺酸伊马替尼的结晶方法

Also Published As

Publication number Publication date
CN103570676A (zh) 2014-02-12
CN105560246B (zh) 2019-07-26
CN105560246A (zh) 2016-05-11
CN103570676B (zh) 2016-03-16

Similar Documents

Publication Publication Date Title
HK1255336A1 (zh) 藥物製劑及其製備方法
HK1205690A1 (zh) 藥物组合物及其施用
PL2814463T3 (pl) Okulistyczne kompozycje farmaceutyczne i sposoby ich wytwarzania i stosowania
HK1203815A1 (zh) 藥物組合物和其製備方法
HK1203149A1 (zh) 阿貝特羅的新劑型和製劑
EP2552447A4 (en) STABLE PHARMACEUTICAL COMPOSITION OF IMATINIB
HRP20180567T1 (hr) Farmaceutski pripravak omeprazola
ZA201409508B (en) Pharmaceutical composition comprising fimasartan and hydrochlorothiazide
HK1208620A1 (zh) 恩替卡韋的藥物組合物及製備方法
HK1214519A1 (zh) 雙用途硫酸鹽口服藥物組合物片劑及其使用方法
GB2504390B (en) Nutraceutical and pharmaceutical composition
EP2844241A4 (en) PHARMACEUTICAL FORMULATION AGAINST BEDS AND METHOD FOR USE THEREOF
ZA201504512B (en) Pharmaceutical composition comprising desloratadine and prednisolone and use thereof
EP2872160A4 (en) NERVO-PROTECTING COMPOSITION AND USE METHOD
HK1220118A1 (zh) 甲磺酸伊馬替尼α結晶的製備及其藥物組合物
HK1204556A1 (zh) 藥物組合物及使用該藥物組合物的準藥物化妝品
IL233961A0 (en) The composition of a phytogenic supplement and methods of its use
ZA201406139B (en) Stable dosage forms of imatinib mesylate
HRP20180781T1 (hr) Farmaceutski pripravak koji sadržava lidipidipin i proces pripreme
EP2814907A4 (en) BORBASTLASTED LIQUID SCINTILLATE COMPOSITIONS AND METHOD OF MANUFACTURING THEREOF
IL234614B (en) Pharmaceutical composition and preparation method thereof
GB201207064D0 (en) Pharmaceutical compositions comprising 15-hetre and methods of using the same